ok...we'll just lower our standards then

[Guest guest]

BIG PHARMA, BAD SCIENCE

From The Nation, July 25, 2002:

In June, the New England Journal of Medicine... made a startling announcement.

The

editors declared that they were dropping their policy stipulating that authors

of

review articles of medical studies could not have financial ties to drug

companies

whose medicines were being analyzed.

 

The reason? The journal could no longer find enough independent experts. Drug

company

gifts and " consulting fees " are so pervasive that in any given field,

you cannot find an expert who has not been paid off in some way by the industry.

So the journal settled for a new standard: Their reviewers can have received no

more than $10,000 from companies whose work they judge. Isn't that comforting?

http://www.gmwatch.org/archive2.asp?arcid=6273

 

 

 

" NOTICE: Due to Presidential Executive Orders, the National Security Agency may

have read this email without warning, warrant, or notice. They may do this

without any judicial or legislative oversight. You have no recourse nor

protection save to call for the impeachment of the current President. "